Skip to main content
. 2023 Nov 21;14:1297950. doi: 10.3389/fendo.2023.1297950

Table 3.

Between-patients evaluation of bone mineral density and pain evolution from baseline (T0) to follow-up visit (T1) according to treatment subgroups.

Alendronate (A) vs Denosumab (D)
T0A T0D p-value T1A T1D p-value
Femoral T-score -1.07 -1.35 0.44 -0.98 -1.39 0.19
Lumbar spine T-score -1.60 -2.26 0.06 -1.45 -1.52 0.74
NRS 4.76 3.88 0.1 4.36 3.52 0.11

NRS, number rating scale.